Clinical Trials on Paraproteinemias in New Zealand
Total 850 results
-
Sorrento Therapeutics, Inc.CompletedRelapsed or Refractory Multiple MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Spain
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Hematologic MalignanciesUnited States
-
University of RochesterCompletedLymphoma | Multiple Myeloma | Myelofibrosis | Solid Tumors | Hematological Disease | Immune DeficienciesUnited States
-
Hackensack Meridian HealthRecruiting
-
Janssen Research & Development, LLCCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | Multiple Myeloma | High-grade B-cell Lymphoma | Refractory B-Cell Lymphoma | DLBCL NOSUnited States
-
AmgenCompletedMultiple MyelomaUnited States, Australia
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.Completed
-
CelgeneThe Leukemia and Lymphoma SocietyCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
Piramal Enterprises LimitedCompletedRelapsed and/or Refractory Multiple MyelomaIndia
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Hackensack Meridian HealthActive, not recruitingLymphoma | Multiple MyelomaUnited States
-
TakedaActive, not recruitingMultiple MyelomaSpain, United States, Australia, China, Korea, Republic of, Canada, France
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Cartesian TherapeuticsCompleted
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)Completed
-
Millennium Pharmaceuticals, Inc.Completed
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterPentixapharm AGRecruitingMultiple Myeloma | Non-Hodgkin Lymphoma | Erdheim-Chester Disease | Rosai-Dorfman Disease | Histiocytic NeoplasmsUnited States
-
Weill Medical College of Cornell UniversityMayo Clinic; Janssen Scientific Affairs, LLCTerminatedWaldenstrom Macroglobulinemia | Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory | Waldenstrom's Disease | Waldenström; Hypergammaglobulinemia | Waldenstrom's Macroglobulinemia of Lymph Nodes | Waldenstrom's Macroglobulinaemia, Without Mention of RemissionUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
Millennium Pharmaceuticals, Inc.Completed
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaUnited States
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedMyelodysplastic Syndromes | Leukemia, Myeloid | Multiple Myeloma | Lymphoma, Malignant | Myelofibrosis | Waldenstrom Macroglobulinemia | Leukemia, LymphoidUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Xcyte TherapiesUnknownMultiple MyelomaUnited States
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
LifeTime PharmaceuticalsUnknownMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States